ZA94845B - Methods for the diagnosis of diabetes and prediabetic conditions - Google Patents

Methods for the diagnosis of diabetes and prediabetic conditions

Info

Publication number
ZA94845B
ZA94845B ZA94845A ZA94845A ZA94845B ZA 94845 B ZA94845 B ZA 94845B ZA 94845 A ZA94845 A ZA 94845A ZA 94845 A ZA94845 A ZA 94845A ZA 94845 B ZA94845 B ZA 94845B
Authority
ZA
South Africa
Prior art keywords
gad
pct
patient
antigen
diabetes
Prior art date
Application number
ZA94845A
Other languages
English (en)
Inventor
Ian Reay Mackay
Merrill Joy Rowley
Paul Zev Zimmet
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Publication of ZA94845B publication Critical patent/ZA94845B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
ZA94845A 1993-02-09 1994-02-08 Methods for the diagnosis of diabetes and prediabetic conditions ZA94845B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL716893 1993-02-09

Publications (1)

Publication Number Publication Date
ZA94845B true ZA94845B (en) 1994-11-11

Family

ID=3776693

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94845A ZA94845B (en) 1993-02-09 1994-02-08 Methods for the diagnosis of diabetes and prediabetic conditions

Country Status (12)

Country Link
US (1) US5770381A (de)
EP (1) EP0686262B1 (de)
JP (1) JP3510889B2 (de)
AT (1) ATE229650T1 (de)
CA (1) CA2155677A1 (de)
DE (1) DE69431874D1 (de)
IL (1) IL108587A (de)
NZ (1) NZ261541A (de)
SG (1) SG45161A1 (de)
TW (1) TW305936B (de)
WO (1) WO1994018568A1 (de)
ZA (1) ZA94845B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
AU3958999A (en) * 1999-06-01 2000-12-18 Kyokuto Pharmaceutical Industrial Co., Ltd. Method for assaying anti-gad antibody and kit
EP2836845B1 (de) 2012-04-13 2018-05-09 DiabetOmics, Inc. Biomarker für schwangerschaftsdiabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
WO1992014485A1 (en) * 1991-02-22 1992-09-03 Amrad Corporation Limited A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
AU1749692A (en) * 1991-05-03 1992-12-21 Novo Nordisk A/S Islet cell autoantigen (gad) for the detection of preclinical diabetes

Also Published As

Publication number Publication date
WO1994018568A1 (en) 1994-08-18
JP3510889B2 (ja) 2004-03-29
IL108587A (en) 1998-01-04
CA2155677A1 (en) 1994-08-18
EP0686262B1 (de) 2002-12-11
EP0686262A1 (de) 1995-12-13
JPH08506417A (ja) 1996-07-09
US5770381A (en) 1998-06-23
ATE229650T1 (de) 2002-12-15
NZ261541A (en) 1996-09-25
IL108587A0 (en) 1994-05-30
DE69431874D1 (de) 2003-01-23
TW305936B (de) 1997-05-21
SG45161A1 (en) 1998-01-16
EP0686262A4 (de) 1997-06-04

Similar Documents

Publication Publication Date Title
Cohen Diabetes and protein glycosylation: measurement and biologic relevance
DeRose et al. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment
Hawa et al. Value of Antibodies to Islet Protein Tyrosine Phosphatase–Like Molecule in Predicting Type 1 Diabetes
Robertson et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: coronary heart disease risk factors in Japan and Hawaii
Bingley et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
Paolini et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies
CA1206877A (en) Immunoassay for nonenzymatically glucosylated proteins and protein fragments - an index of glycemia
Rosse et al. Paroxysmal nocturnal haemoglobinuria
Peacock Glycosylated haemoglobin: measurement and clinical use.
Withold Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers
CA2104225A1 (en) Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
Beischer et al. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes
Hanson et al. Hormonal regulation of hepatic P-enolpyruvate carboxykinase (GTP) during development
Power et al. Blood glucose and prognosis of acute stroke
SG45161A1 (en) Methods for the diagnosis of diabetes and prediabetic conditions
Muhr et al. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
Docherty et al. Myoglobin concentration, creatine kinase activity, and creatine kinase B subunit concentrations in serum during thyroid disease.
Meek et al. Radioimmunoassay of insulin A and B chains in normal and diabetic human plasma
Naylor et al. Does treatment with essential amino acids and hypertonic glucose improve survival in acute renal failure?: A meta-analysis
Kishihara et al. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes
ATE221200T1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
Sackey et al. Interval between insulin injection and breakfast in diabetes.
Shin et al. Glycated haemoglobin and glycated albumin: evaluation of different methods in diabetic control
US5518886A (en) Blood lead diagnostic assay